It is considered a more specific clinical marker, compared to CA125, for the diagnosis of ovarian cancer at an early stage with a serum cut-off level of 70 pmol/mL, above which there is a high suspicion of ovarian cancer [105]. This evidence concerns the gene MUC16 and ovarian carcinoma.